Squamous Cell Carcinoma
New Squamous Cell Carcinoma Study Findings Recently Were Published by W. Wang and Co-Researchers
Published in Gene Therapy Weekly, May 26th, 2011
2011 MAY 26 -- According to recent research from Zhengzhou, People's Republic of China, "Esophageal squamous cell carcinoma (ESCC) is one of the most frequently diagnosed malignant tumors in North China. We have identified that Wnt2/beta-catenin pathway is activated in ESCC cells and sodium nitroprusside (SNP) and siRNA against beta-catenin not only inhibit the expressions of beta-catenin and its major downstream effectors including c-myc and cyclin D1 but induce cell cycle arrest and apoptosis."
"The purpose of the present study was to analyze the relationship between pathological parameters including invasion depth and lymph node metastasis and the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-05-26)
More Articles from Gene Therapy Weekly
- Antisense Technology
Data on Antisense Technology Described by Researchers at Shanghai Jiao Tong University School of Medicine - Gene Therapy
Data on Gene Therapy Reported by Researchers at Children's Hospital - Leukemia
Data on Leukemia Discussed by Researchers at Soochow University - Neutral Amino Acids
Findings from National Cancer Institute Provide New Insights into Neutral Amino Acids - Doxorubicin Therapy
Findings from University of Hamburg Advance Knowledge in Doxorubicin Therapy - Gene Therapy
Findings in Gene Therapy Reported from Tianjin University - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
